Modes of action of the DNA methyltransferase inhibitors azacytidine and decitabine
By Carlo Stresemann, F. Lyko. International Journal of Cancer, 2008
892 citations recorded by the source corpus.
Subfields: Hematology, Molecular Biology, Virology
View Paper: https://www.semanticscholar.org/paper/95cdc48eb5858fa544030584fd0e88a316dee49d
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
- Fabian López-Vallejo
- Karina Martínez-Mayorga
- José L. Medina-Franco
- Marc A. Giulianotti
- Adel Nefzi
- Thomas R. Caulfield
- Richard A. Houghten
- E. Raiber
Citations in the corpus
- Integrating virtual screening and combinatorial chemistry for accelerated drug discovery. (2011, background): “These two drugs are nucleoside analogues, which after incorporation into DNA, cause covalent trapping and subsequent depletion of DNA methyltransferases [55, 56].”
- Mapping and elucidating the function of modified bases in DNA (2017, background): “For example, the ribo- and deoxyribonucleoside analogues of 5-azacytidine are currently used in the clinic to treat cancer including leukemia.(114) They are thought to become phosphorylated on three sites before being incorporated into genomic DNA during replicative DNA synthesis.”